NewGenIvf (NIVF) Operating Expenses (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Operating Expenses of $790006.0 for Q4 2025, down 30.47% year-over-year from $1.1 million in Q4 2024, and down 76.63% quarter-over-quarter from $3.4 million in Q3 2025.
NewGenIvf (NIVF) Operating Expenses (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has reported Operating Expenses for 2 consecutive years, with $790006.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Expenses fell 30.47% year-over-year to $790006.0; the TTM figure through Dec 2025 stood at $5.3 million (up 211.2% YoY), while the FY2025 annual figure was $616423.0, down 20.84% from the prior year.
- Operating Expenses declined to $790006.0 in Q4 2025 per NIVF's latest filing, from $3.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $3.4 million in Q3 2025 and bottomed at $569067.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 17.74 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 3.00 Mn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 1.31 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 2.98 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 1.32 Bn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 4.12 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 1.32 Bn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 584.05 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 490.51 Mn |
| 10 | NewGenIvf | 9,048.24 | -1.43 Mn | 524,025.00 | 790,006.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 790,006.00 |
| Sep 30, 2025 | 3.38 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 569,067.00 |